DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

BACKGROUND: Hyperglycemia and insulin resistance often develop cardiovascular and nephrological dysfunction in diabetic patients. Sitagliptin is used to treat diabetes and showed potential benefit in lowering increased blood glucose level in diabetes. This investigation reports the effect of sitagli...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Md. Ashraful, Chowdhury, Mohammed Riaz Hasan, Jain, Preeti, Sagor, Md. Abu Taher, Reza, Hasan Mahmud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658771/
https://www.ncbi.nlm.nih.gov/pubmed/26609328
http://dx.doi.org/10.1186/s13098-015-0095-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658771/
https://www.ncbi.nlm.nih.gov/pubmed/26609328
http://dx.doi.org/10.1186/s13098-015-0095-3

Ejemplares similares